These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Lombard Z; Dalton DL; Venter PA; Williams RC; Bornman L Hum Immunol; 2006 Aug; 67(8):643-54. PubMed ID: 16916662 [TBL] [Abstract][Full Text] [Related]
12. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230 [TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. Bonecini-Almeida MG; Chitale S; Boutsikakis I; Geng J; Doo H; He S; Ho JL J Immunol; 1998 May; 160(9):4490-9. PubMed ID: 9574555 [TBL] [Abstract][Full Text] [Related]
15. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis. Yadav AB; Muttil P; Singh AK; Verma RK; Mohan M; Agrawal AK; Verma AS; Sinha SK; Misra A Tuberculosis (Edinb); 2010 May; 90(3):188-96. PubMed ID: 20382085 [TBL] [Abstract][Full Text] [Related]
16. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
17. Human splenic macrophages as a model for in vitro infection with Mycobacterium tuberculosis. Henao J; Sánchez D; Muñoz CH; Mejía N; Arias MA; García LF; Barrera LF Tuberculosis (Edinb); 2007 Nov; 87(6):509-17. PubMed ID: 17765662 [TBL] [Abstract][Full Text] [Related]
18. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938 [TBL] [Abstract][Full Text] [Related]
19. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment. Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096 [TBL] [Abstract][Full Text] [Related]
20. Role of Chicoric Acid and 13-Cis Retinoic Acid in Mycobacterium tuberculosis Infection Control by Human U937 Macrophage. Abd-Nikfarjam B; Nassiri-Asl M; Hajiaghayi M; Naserpour Farivar T Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):399-406. PubMed ID: 29704020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]